News archive

Lifecare AS (LIFE) Digid Cantisense Update

March 19, 2021
March 19th, 2021,Bergen – Lifecare’s partner, Digital Diagnostics AG (Digid), has developed a novel 5-minute antigen rapid virus detection test. The Cantisense test method is based on proteins binding onto the virus antigen, which leads to electronically measurable changes. The method is highly sophisticated and advanced compared to already existing virus detection test methods:   […]
Read more

Regulatory approval for first-in-human Clinical Pilot Evaluation

February 15, 2021
Lifecare has received regulatory approval for thefirst-in-human Sencell Clinical Study Protocol from the German FederalInstitute for Drugs and Medical Devices (BfArM). With this final remaining approval, Lifecare has reached its goal to have clinical pilot trial permission as planned in Q1 2021.   “With this regulatory approval, Lifecare has achieved amajor milestone in the development […]
Read more

Lifecares EU funded project FORGETDIABETES featured in the Norwegian Diabetes Association’s magazine “Diabetes”

January 15, 2021
The Norwegian Diabetes Association recently published an article in their magazine“Diabetes” about the EU funded project FORGETDIABETES where Lifecare and academic partners in Italy, Germany and France aim to develop a bionic invisible pancreas. In the article the General Secretary of the Norwegian Diabetes Association, Mr. Bjørnar Allgot, and Prof. Dr. Pål Rasmus Njøstad, who […]
Read more